BiotechTubeBiotechTube
Home/Investors/Other institutional public market investors

Other institutional public market investors

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$2.1B
Focus Areas
8
Top Stage
Commercial

Investment Focus

Rare DiseasesOncologyNeurologyCardiologyPrenatal HealthFibrotic DiseasesPulmonaryHepatology

Portfolio Companies

CompanyValuation
GeneDx Holdings$2.0B
Pliant Therapeutics$79.9M

Frequent Co-Investors

Venrock1 sharedDeerfield Management1 sharedCasdin Capital1 sharedSection 321 sharedGV (Google Ventures)1 sharedNovartis Venture Fund1 shared